Scarica l'app Stockscreener
42.24
1.68%
-0.72
Dopo l'orario di chiusura:
42.24
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Vera Therapeutics, Inc. $VERA Shares Purchased by Candriam S.C.A. - MarketBeat
Vera Therapeutics, Inc. (VERA): A Bull Case Theory - Insider Monkey
Assessing Vera Therapeutics (VERA) Valuation As Atacicept Nears FDA Decision And Commercial Leadership Shifts - Sahm
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com
Quarterly Earnings: Can Vera Therapeutics Inc deliver consistent EPS growthJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Two new Vera Therapeutics hires get stock options and 4-year RSUs - Stock Titan
(VERA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is Vera’s New Commercial Chief for Atacicept Reshaping the Investment Case for Vera Therapeutics (VERA)? - Sahm
Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 65.98% Potential Upside for a Biotech Innovator - DirectorsTalk Interviews
Is Vera’s New Commercial Chief And Atacicept Launch Push Altering The Investment Case For Vera Therapeutics (VERA)? - Yahoo Finance
Vera Therapeutics Readies Atacicept Launch As New CCO Joins, Valuation Lags - Yahoo Finance
Vera Therapeutics Appoints New Chief Commercial Officer - intellectia.ai
Vera Therapeutics Adds CCO As Atacicept Advances And Valuation Gap Persists - Sahm
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Vera Therapeutics (VERA) One of the Best High Short Interest Stocks with Biggest Upside Potential? - Insider Monkey
Is Vera Therapeutics (VERA) one of the best high short interest stocks with biggest upside potential? - MSN
Y Intercept Hong Kong Ltd Buys New Shares in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. $VERA Shares Bought by J. Safra Sarasin Holding AG - MarketBeat
Is Vera Therapeutics (VERA) Attractive After Recent Share Price Pullback And DCF Upside? - simplywall.st
Aug Intraday: Whats next for Digimarc Corporation stockNew Guidance & Technical Pattern Recognition Alerts - baoquankhu1.vn
Vera Therapeutics promotes Matt Skelton to chief commercial officer By Investing.com - Investing.com South Africa
Vera Therapeutics promotes Matt Skelton to chief commercial officer - Investing.com
Vera Therapeutics Appoints Matt Skelton as Chief Commercial Officer Amid Commercial Launch Preparations for Atacicept - Quiver Quantitative
Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer - The Manila Times
Shorts Report: Is LMAT subject to activist investor interestWeekly Trade Summary & High Accuracy Investment Signals - baoquankhu1.vn
Vera Therapeutics, Inc. (VERA) Stock Analysis: Unpacking A 59% Upside Potential - DirectorsTalk Interviews
JPMorgan reiterates Overweight rating on Vera Therapeutics stock By Investing.com - Investing.com Canada
Assessing Vera Therapeutics (VERA) Valuation After Phase Three Success And AI Drug Discovery Progress - Sahm
Responsive Playbooks and the VERA Inflection - Stock Traders Daily
What Vera Therapeutics (VERA)'s Phase 3 Kidney Trial Win and AI Push Mean For Shareholders - Sahm
Big Picture: Does Vera Therapeutics Inc align with a passive investing strategy - baoquankhu1.vn
Clinical Success Lifts Vera (VERA) Shares, Boosting Fund Returns - Yahoo Finance
SG Americas Securities LLC Takes $911,000 Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Buyout Rumor: Is Vera Therapeutics Inc vulnerable to short sellersWeekly Investment Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Insider Buy: Whats the analyst consensus on Vera Therapeutics IncTake Profit & Safe Capital Investment Plans - baoquankhu1.vn
Cantor Fitzgerald reiterates Overweight rating on Vera Therapeutics stock By Investing.com - Investing.com Canada
Published on: 2026-01-16 22:59:19 - baoquankhu1.vn
Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept - Insider Monkey
14 Best Booming Stocks to Buy Right Now - Insider Monkey
Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High? - sharewise.com
Understanding the Setup: (VERA) and Scalable Risk - Stock Traders Daily
Vera Therapeutics, Inc. (VERA) Stock Analysis: A 62% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Vera Therapeutics (NASDAQ:VERA) Shares Down 7.4%Here's Why - MarketBeat
Why Vera Therapeutics stock zoomed higher today - MSN
Assessing Vera Therapeutics (VERA) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Short report: Vera Therapeutics bears retreat as stock rallies - MSN
Does FDA Priority Review For Atacicept Reshape The Bull Case For Vera Therapeutics (VERA)? - Yahoo Finance
Will Vera Therapeutics Inc. stock split again soonJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - Улправда
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):